bankruptcy uBiome Files for Chapter 7 Liquidation The company had previously declared Chapter 11 bankruptcy, which would have enabled it to reorganize to stay afloat and pay its creditors over time. uBiome Declares Bankruptcy, Offers Assets for Sale The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months. Vela Diagnostics Accelerates Entry Into US Microbiology Market With Great Basin Buy Premium Vela purchased Great Basin for $1.4 million in June, and will reopen its Utah-based lab, rehire employees, and commercialize the firm's infectious disease platform. Rosetta Genomics Files for Chapter 7 Bankruptcy Rosetta had disclosed that it intended to file for bankruptcy after its merger with Genoptix was not completed as planned. 3D Signatures Lays Off Employees, Will Declare Bankruptcy The company is developing tests based on the analysis of the spatial patterns of chromosomes by tagging and imaging their telomeres. Jun 26, 2017 Eurofins to Acquire Genoma May 12, 2017 Premaitha Vows to Recover $970K From Bankrupt Swiss Customer Genoma, Take Over NIPT Business Apr 14, 2017 NanoMolecular DX Purchases Nuclea's Assets for $330K Premium Mar 17, 2017 Nuclea's Former CEO Attempting to Buy Company's Assets in Bankruptcy Dec 21, 2016 Nuclea to Auction Assets as Part of Chapter 7 Bankruptcy Proceedings Premium Sep 16, 2015 Bankruptcy Court Approves True Health Dx's $37.1M Bid for HDL's Assets Sep 11, 2015 True Health Dx Set to Buy HDL's Assets for $37.1M Sep 4, 2015 True Health Submits $32M Stalking Horse Bid for HDL Jul 31, 2015 Currently in Chapter 11, Natural Molecular Testing Will Shut Down, Repay CMS $71M Oct 17, 2013 US Subsidiary of ZyGem Shuttered After Forced Bankruptcy; Questions Surround Asset Disbursement Premium Jun 17, 2013 Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche Mar 11, 2013 Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company Jan 31, 2013 Marina Defaults on Loan as Bankruptcy Looms Premium Dec 12, 2012 Synthetic Bio Firm GeneForge Files for Chapter 7 Bankruptcy Nov 16, 2012 Helicos BioSciences Files for Chapter 11 Bankruptcy Protection Oct 18, 2012 Marina Says Cash Will Run out at the End of the Month, Reports 2011 Financials Premium Aug 23, 2012 Traversa Responds to Former Execs Bid to Block Sale of IP in Bankruptcy Proceedings Premium Aug 16, 2012 Former Traversa Exec Moves to Block Sale of Certain IP in Bankruptcy Proceedings Premium Apr 11, 2012 Helicos Sells Certain MDx IP to Sequenom for $1.3M, Warns of Potential Bankruptcy Apr 5, 2012 With Just Two Months' Cash on Hand, Rosetta Genomics Again Facing Bankruptcy Premium Load More Breaking News Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.